Table 2. Distribution of patients over the risk groups for all patients (n = 1892) and BCG treated patients (n = 449).
| Risk category | CUETO | EORTC | ||||||
| Recurrence | Progression | Recurrence | Progression | |||||
| All patients (N = 1892) | ||||||||
| Low risk | 1195 | (63.2%) | 1289 | (68.1%) | 383 | (20.2%) | 346 | (18.3%) |
| Intermediate risk | 421 | (22.3%) | 135 | (7.1%) | 1099 | (58.1%) | 929 | (49.1%) |
| High risk* | 276 | (14.6%) | 468 | (24.7%) | 410 | (21.7%) | 617 | (32.6%) |
| BCG (N = 449) | ||||||||
| Low risk | 226 | (50.3%) | 241 | (53.7%) | 48 | (10.7%) | 30 | (6.7%) |
| Intermediate risk | 136 | (30.3%) | 36 | (8.0%) | 257 | (57.2%) | 197 | (43.9%) |
| High risk* | 87 | (19.4%) | 172 | (38.3%) | 144 | (32.1%) | 222 | (49.4%) |
*The high risk group is the combined group from intermediate-high and high-risk EORTC and CUETO scores, because of low patient numbers.